Try our Advanced Search for more refined results
Life Sciences - June, 2007
142 articles
- Judge Issues Mixed Ruling In Chip Patent Case
- Federal Circuit Keeps Takeda's Win Streak Alive
- AstraZeneca Asserts Seroquel Patent Against Teva
- Dey Buries Hatchet With States In Drug Pricing Suit
- Sales Reps Sue Abbott For Overtime Pay
- University, Biotechs Squabble Over Genetic Testing
- Doubt Cast On Anti-Depressant/Birth Defect Link
- AsymmetRx Sues Rivals Over Cancer Diagnostic Test
- Stem Cell Patent Dispute Stayed Until PTO Ruling
- GSK To Generics: Hands Off Paxil Patents
- FDA, SEC Disclosure: Standard Procedures Can Help
- A New Breed Of Products-Based Litigation
- Ortho Evra Plaintiffs' Lawyers Gear Up For Class Action
- Pfizer Doesn't Owe Attorneys' Fees, Court Says
- Supreme Court Will Hear Regulatory Preemption Case
- J&J Wants Ortho Evra Documents Kept Under Wraps
- Battle Rages On In Seroquel Case
- Novogen Settles Patent Spat Over Menopause Patents
- Bone Cancer Drug Suits Try To Break Novartis
- Court Nixes Pfizer's Bid To Toss Nigeria Suit
- Purchasers Seek Class Status In Ditropan Case
- After Loss, Drug Makers Move To Toss Separate Case
- Wyeth Wants To Dump Old PPA Case Files
- High Court Refuses To Hear Authorized Generics Suit
- Judge Tosses Ephedra Claim
- Wyeth Sues Sandoz Over Generic Effexor
- Tough Road Lies Ahead For Proposed Biologics Bill
- Teva Files Ninth Suit Over Heart Failure Drug
- Goldshield Pays £4M To Settle Price-Fixing Allegations
- Drug Middlemen Pan Judge Over Subpoena Denial
- J&J Unit Faces Scrutiny After $5M Jury Loss
- Dewey Ballantine Grabs Three Robins Kaplan Partners
- Teva Sues Over Congestive Heart Failure Drug
- Shelhigh Agrees To Halt Production Of Seized Devices
- Guidant Seeks To Exclude Testimony
- Forest Cries Foul In Celexa/Lexapro Filing Chaos
- Alza Challenges Antitrust Claims In Ditropan Case
- Suits Contend Pfizer Drug Sparks Gambling Addiction
- DenTek Chomps Trade Secret Claims
- Litigator Reunites With Colleagues At Heller Ehrman
- Judge Finds Drug Makers Liable For Inflating Costs
- Sanofi Fires New Round Of Infringement Claims
- J&J Continues To Face Prosthetic Knee Suits
- Chemical Co. Sues Over Transdermal Patch Patent
- House Committee Greenlights Safety Bill
- Abbott Sues Impax Over Depakote
- Plaintiffs Win More Time To Seal Glaxo Deal
- Wyeth Loses First Diet Pill Trial Of 2007
- Court Shakes Head At Novartis In Famvir Spat
- Court Vacates Injunction In Pipe Fitting Patent Suit
- Israeli Co.'s Appeal Dies at the Supreme Court
- U.S., Europe Revamp Drug Regulation Pact
- Apotex To Appeal Court's Plavix Patent Ruling
- Bellwether Plaintiff Prepares For Guidant Trial
- J&J Subsidiaries Hope For Another Dismissal
- Biomedino's Blood-Cleaning Patent Found Invalid
- Forest Tries To Block Plaintiff In Celexa/Lexapro Suits
- Attacking Product Recall Evidence Under Daubert
- Becton Dickinson Sued Over Syringe Patents
- Alleged Vioxx Deception Earns Attys. $4M
- Judge Issues Blow To Accutane Plaintiffs
- Williams Bailey Tops List Of Suit-Happy Firms
- Prempro Plaintiffs Demand Docs From Wyeth
- Supplement Containing Impotence Drug Recalled
- Judge Bounces Bextra, Celebrex Claims
- BMS Avoids Charge As Prosecution Deal Expires
- Tyco Unit Challenges OxyContin Patents
- Vet Co. Sues Pfizer Over Drug Marketing Practices
- State's Bid To Get Zyprexa Case On Home Turf Denied
- Sanofi Fights To Hang On To Eloxatin
- F.D.A. Panel Rejects Drug for Obesity
- Eisai Patent Win Pains Antitrust Claimants
- Merck Tops List In Pharma Class Actions
- Bloomberg Moves To Unseal Guidant Court Papers
- Pharmaceutical Liability Will Turn On Preemption
- Attorney Ads Make Mentally Ill Stop Taking Drugs: Lilly
- Blame Over Fosamax Draws Sharp Debate
- Plaintiffs Eye Punitive Pay Against Bausch & Lomb
- Ortho-McNeil, Plaintiffs Skirt Calif. Venue
- Suit Against Boston Scientific Officers Dismissed
- KV Brings Antitrust Allegations To Patent Suit
- Pfizer Heaps Another $100M Onto Asbestos Trust
- Judge Nixes Bids To Toss Heart Device Claims
- A Look at KSR
- Cordis, Abbott Continue Battle Over Stent Patents
- Warner Chilcott Drops $5.5M In Ovcon Settlement
- ImClone Fires Counsel Following Sanctions
- Medtronic Asserts Corrected Claims Against Cordis
- Lilly Settles Scores Of Zyprexa Suits
- GSK Faces More Headaches Over Avandia
- High Court Nixes Pfizer's Bid For Quick Review
- Bristol-Myers Bids To Exclude Evidence
- Discovery In Seroquel Cases Gets OK
- Autism Case Sparks Debate Over Vaccine Program
- Ortho-McNeil Denies Birth-Control Patch Claims
- Medtronic Braces For Face-Off In Court
- Judge Stays Schering Clarinex Patent Suit
- Court Sanctions ImClone, IP Attorneys
- Suit Alleges Biotech Firm Lied About FDA Trials
- Express Scripts Gets Fraud Charges Dismissed
- Pfizer Seeks To Toss Celebrex, Bextra Cases
- Metabolife Settles More Ephedra Claims
- Proveris Wins Permanent Injunction Against Rival
- Purdue Sues KV Over OxyContin Patent
- Teva, Novartis To Compete For Generic Lotrel
- Court To Hear Ex-Employee's Case Against Pfizer
- AstraZeneca Settlement Has Consumer Class Split
- Plaintiffs Bash Broad Take On Twombly
- Pfizer Sues Teva Over Lipitor Patent
- Rite Aid Sued Over Alleged Union Suppression
- AstraZeneca Hit With Wage-And-Hour Suit
- Congress Weighs Value Of Pediatric Exclusivity
- Proposed IP Protection Act Sparks Controversy
- Novartis Bone Drug Suit Grows
- Appraisal Arbitrage May Be A Hedge Fund Strategy
- Judge Denies Fresenius' Bid For Stay In Patent Case
- Companies' Letter Demands Biologic Bill Passage
- Judge Rules Pepcid Complete Patent Is Invalid
- Appellate Court Remands ERISA Suit Against Guidant
- Defamation Suit Against J&J Moved To Federal Court
- Union Sues J&J Over Off-Label Uses Of Risperdal
- Consumers Urge High Court To Hear Tamoxifen Cases
- Pfizer Fights Bid To Keep Bextra Case In State Court
- Cordis Says Medtronic Stent Patents Unenforceable
- Nigeria Sues Pfizer For $7B Over Drug Trials
- Watson, Sun Seek Attorneys' Fees From Novartis
- Rite Aid Acquires 1,800+ Stores With Divestitures
- Circuit Reaffirms Invalidity of Pfizer's Norvasc Patent
- Abbott Accused Of Inflating Drug Prices By 1000%
- Proposed Inpatient Rule To Affect Specialty Hospitals
- FDA Commissioner Defends Reaction To Avandia
- FDA Proposes Committee For Risk Communication
- Barr, Lilly Dismiss Prozac Patent Suit
- Judge Says Impax, Apotex Infringed Prilosec Patents
- Abbott Accuses Health Officials In Medicare Suit
- Lerach Awarded More Than $3M
- Pfizer Asks For Quick Review In Norvasc Feud
- EPA Probe Of Power Plant, Health Care Facility Waste
- Merck Witness' Omission Leads To New Vioxx Trial
- Express Scripts Sued Over Patient ID Cards
- More Sales Reps Join Novartis Overtime Lawsuit
- Glaxo Slapped With Avandia Personal Injury Suit